TNYA
Tenaya Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.68
−1.52%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.10
- Revenue estimate
- $802.5K
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- -$0.20
- EPS estimate
- -$0.07
- Revenue actual
- $1.1M
- Revenue estimate
- $10.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- -40.4%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026